Salomon & Ludwin
AMRX icon

Salomon & Ludwin’s Amneal Pharmaceuticals AMRX Stock Holding History

Salomon & Ludwin’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.3K Hold
711
– – ﹤0.01% 1149
2026
Q2 		$12.1K Buy
711
+515
+263% +$7.06K ﹤0.01% 1500
2026
Q1 		$2.45K Buy
+196
New +$2.63K ﹤0.01% 1909

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tucker Asset Management
Tucker Asset Management Littleton, Colorado $406M AUM 20.49% 1-Year Est. Return
Quartz Partners
Quartz Partners Saratoga Springs, New York $330M AUM 17.57% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Signature Wealth Management Partners
Signature Wealth Management Partners Montvale, New Jersey $234M AUM 23.06% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Virtus Wealth Solutions
Virtus Wealth Solutions Cranford, New Jersey $589M AUM 192.69% 1-Year Est. Return

Salomon & Ludwin's AMRX Position: Q3 2026 in Review

Salomon & Ludwin held its Amneal Pharmaceuticals (AMRX) position steady in Q3 2026 at 711 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Salomon & Ludwin first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Salomon & Ludwin held 711 shares of Amneal Pharmaceuticals worth $14.3K as of Q3 2026.
  • Salomon & Ludwin left its Amneal Pharmaceuticals share count unchanged in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1149 holding.
  • Salomon & Ludwin first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.